HPV vaccine : can we afford to hesitate?

Loading...
Thumbnail Image

Authors

Richter, Karin Louise
Dreyer, Greta
Lindeque, B. Gerhard
Botha, M.H.

Journal Title

Journal ISSN

Volume Title

Publisher

Health and Medical Publishing Group

Abstract

Cervical cancer, caused by human papillomavirus (HPV) infection, is highly prevalent in sub-Saharan Africa. The estimated annual incidence of cervical cancer is 35/100 000 women, with 22.5/100 000 associated deaths. This is in stark contrast to the 6.6/100 000 cases and 2.7/100 000 deaths reported in developed countries such as the USA, where HPV vaccination has been available since 2006.

Description

Keywords

Cervical canver, HPV vaccine, Human papillomavirus (HPV), Vaccination

Sustainable Development Goals

Citation

Richter, KL, Dreyer, G, Lindeque, BG & Botha, MH 2014, 'HPV vaccine : can we afford to hesitate?', South African Medical Journal, vol. 104, no. 8, pp. 522-523.